Levels Of Depression In Patients Research Articles

Decreased Functioning and Contents of Worries Associated with Anxiety or Depression Symptom Levels Within Patients Hospitalized with COVID-19 Infection.

High levels of anxiety and depression symptoms have been reported in patients with COVID-19 compared to the general population. These symptoms were related to variables such as gender, age, and education level with anxiety/depression levels. We aimed to determine the relationship between anxiety and depression symptoms and epidemic-related decreased functioning, worry, and quality of life (QoL). The study included 238 hospitalized participants due to COVID-19 and 168 participants who were hospitalized for reasons other than COVID-19. The Hospital Anxiety and Depression Scale (HADS), Short Form 36 (SF-36) QoL Scale, and questionnaires prepared by the researchers were applied. The effects of current worries, impairment in QoL, and decreased functioning during quarantine on levels of anxiety and depressive symptoms were investigated by implementing multiple linear regression analyzes. Our study results suggested the anxiety and depression levels of patients with COVID-19 were not higher than those in the internal medicine inpatient unit at the same time. Worries about transmission to others, uncertainty, social media news, and health anxiety increased the psychiatric symptoms of participants with COVID-19. Disruptions in social relationships and health also have an effect on anxiety/depression symptom levels. Conversely, results indicated losses and worries in occupation and finance did not significantly affect mental symptoms. Worries about transmission to others, uncertainty and health anxiety are closely related to anxiety and depression among patients with COVID-19. There is a need for research in the mental health field for the later stages of the pandemic in different cultures.

Health-related quality of life (HRQoL), anxiety and depression in patients with ureteral stricture: a multi-institutional study.

To evaluate health-related quality of life (HRQoL), anxiety and depression levels in patients with ureteral stricture (US) and to further investigate factors independently affecting this. We prospectively recruited a cohort of 275 consecutive patients with US between June 2020 and April 2021. The participants were required to provide complete sociodemographic, clinical and pathologic information. All patients were administered questionnaires to evaluate HRQoL, anxiety and depression. Multivariate linear regression analyses were performed to assess the contribution of covariates on HRQoL, anxiety and depression. Patients with US, particularly iatrogenic US, scored significantly lower than the Chinese general population in all domains of the SF-36 (all p < 0.001), except SF. Increased age, female and high education attainment were independently associated with poor HRQoL. Interestingly, iatrogenic US, nephrostomy tube placement, urinary symptoms, high anxiety and depression level independently predicted poor HRQoL. Furthermore, the percentages of anxiety and depression cases in patients with US were 31.3% and 20.7%, respectively. Iatrogenic US and urinary symptoms, specifically waist discomfort, were the strongest predictors of increased levels of anxiety and depression. Patients with US exhibited poor quality of life and emotional status. Various factors independently predicted worse HRQoL and emotion, which provide potential targets for medical, lifestyle-related, psychological interventions.

Relationship between disease severity, perceived stress, and depression in patients with seborrheic dermatitis

Objective: A significant proportion of patients with seborrheic dermatitis state that disease attacks are triggered by psychological stress and disease severity increases during stressful times. This study aimed to determine the relationship between disease severity and perceived stress and depression levels in patients with seborrheic dermatitis. Patients and Methods: The patients’ demographic characteristics, medical history, and Seborrheic Dermatitis Area Severity Index (SDASI), Perceived Stress Scale (PSS), and Beck Depression Inventory (BDI) scores were recorded, and the relationship between disease severity and the scale scores were statistically analyzed by comparing disease severity groups and using correlation analyses. Results: The study included 120 patients with seborrheic dermatitis. The mean age of the patients was 29.5±8.2 years, and the female/ male ratio was 49/71. According to disease severity, 66 (55%) patients were classified as mild, 30(25%) moderate, and 24 (20%) as severe seborrheic dermatitis. When the scale scores were evaluated, a significant positive correlation was found between SDASI and PSS (r=0.767, p&amp;lt;0.001), between SDASI and BDI (r=0.663, p&amp;lt;0.001), and between PSS and BDI (r=0.687, p&amp;lt;0.001). Conclusion: A significant relationship was observed between disease severity, stress, and depression in patients with seborrheic dermatitis. There is a need for a multidisciplinary approach involving a dermatologist and psychiatrist in the follow-up and treatment of these patients.

A randomized controlled trial of a coping-focused family resilience intervention program for breast cancer patients: Study protocol.

BackgroundBreast cancer patients and their families are under various pressures in the process of disease diagnosis and treatment, which seriously threaten their physical and mental health. Findings from existing research suggest that good family resilience can help breast cancer families better adapt and cope with adversity and challenges. However, there are only a few intervention studies on family resilience and no intervention studies on resilience among the families of breast cancer patients. Therefore, this study aims to explore appropriate measures to improve the resilience level of breast cancer families and help them better cope with the disease.ObjectiveThe purpose of this study protocol is to demonstrate a coping-focused family resilience intervention to increase the level of resilience in the families of breast cancer patients and help them better cope with adversity.MethodsThe trial will recruit 80 breast cancer families and randomly assign them to experimental and control groups in a 1:1 ratio. The control group will receive routine care, and the intervention group will receive a 6-week one-on-one online family resilience intervention based on the control group. Two groups of subjects will be assessed at baseline and at 1 week, 1 month, and 3 months after the intervention. The primary outcome is family resilience, and the secondary outcomes are coping style, social support, family disease burden, and levels of anxiety and depression.Expected resultsWe hypothesized that after the intervention, the intervention group would have significantly higher levels of family resilience than the preintervention and control groups. In the intervention group, other aspects related to family resilience, such as family disease burden and anxiety and depression levels of patients and their families, were significantly alleviated, and disease coping and social support levels were improved accordingly.DiscussionIf the program works, it can help breast cancer families identify family strengths and resources to proactively address challenges so that families can successfully navigate the crisis and patient and family recovery can be facilitated. It can also provide a practical path for clinical workers to help breast cancer families adjust rationally.Clinical Trial RegistrationThis study has been registered in the Chinese Clinical Trials Registry (Registration Number: http://www.chictr.org.cn/ChiCTR2100052108).

The Effect of Assertive Behavior on Depression in Diabetes Mellitus Patients

The purpose of research is to know about the effect of assertive behavior to depression on diabetes mellitus patients. This study used pre-experimental design with ao ne-group pre-post test t design. The sample used is 1 7 people selected by purposive sampling technique. The results showed that the category of depression before being given assertive behavior treatment mostly in the moderate depression as many as 1 1 people (64.7%), and after being given assertive behavior showed that a decrease in the number of moderate depression to be 9 people ( 52.9 %). The results of this study were tested by paired-sample t-test statistic, the results obtained value (р) = 0.01 5 . The conclusion of research is assertive behavior can decrease the level of depression in patients with diabetes mellitus.

The Effect of Assertive Behavior on Depression in Diabetes Mellitus Patients

The purpose of research is to know about the effect of assertive behavior to depression on diabetes mellitus patients. This study used pre-experimental design with ao ne-group pre-post test t design. The sample used is 1 7 people selected by purposive sampling technique. The results showed that the category of depression before being given assertive behavior treatment mostly in the moderate depression as many as 1 1 people (64.7%), and after being given assertive behavior showed that a decrease in the number of moderate depression to be 9 people ( 52.9 %). The results of this study were tested by paired-sample t-test statistic, the results obtained value (р) = 0.01 5 . The conclusion of research is assertive behavior can decrease the level of depression in patients with diabetes mellitus.

Personality Characteristics, Anxiety Sensitivity, Anxiety, and Depression Levels on Patients Diagnosed with Psychogenic Pruritus.

This study aimed to investigate the personality traits, anxiety sensitivity (AS), anxiety, and depression levels in patients diagnosed with psychogenic pruritus (PP). Certain personality traits may come to the fore in psychosomatic disorders; these traits are thought to make the person vulnerable to psychosomatic diseases. This study aimed to investigate the personality traits, anxiety sensitivity (AS), anxiety, and depression levels in patients diagnosed with psychogenic pruritus (PP). Thirty-seven patients diagnosed with PP (patient group) and 21 healthy controls were included in the study. Sociodemographic Data Form, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Anxiety Sensitivity Index-3 (ASI-3), and Eysenck Personality Questionnaire (EPQ) were administered to all participants. Patients' EPQ scores for the extraversion, neuroticism, psychoticism, and lie subdimensions and EPQ-total scores were significantly higher than those of the control group (P = .001; P < .001; P < .001; P = .008; P < .001, respectively). The total score of ASI-3 scale and the scores of all subdimensions (physical, cognitive, and social) were significantly higher in patients than in controls (P < .001). The BAI (26.8 ± 9.3) and BDI (24.2 ± 8.6) total scores of the patients were significantly higher than those of the control group (P < .001). According to EPQ, patients diagnosed with PP are extroverted, but also cold, distrustful, and aloof; show impulsive behavior; are anxious, depressed, and nervous; overly emotional; and prone to lying. Patients suffer more from anxiety, depressive symptoms, and AS in physical, cognitive, and social subdimensions than healthy people. Our findings highlight the importance of psychiatric assessment in PP patients. In this context, we believe that PP deserves to be studied in a broad spectrum with its cognitive, behavioral, and social aspects.

Vitamin C for the Treatment of Depression in Cancer Patients: A Literature Review

Introduction: One in two Canadians will be diagnosed with cancer in their lifetime and one in four will experience depression during their diagnosis. The cause of depression during cancer could be related to psychological, social, inflammatory, or immunological factors. Vitamin C can exert an effect on oxidative stress levels, adrenal function, and immune function and may have a role in the treatment of both cancer and depression. Vitamin C levels can affect neurotransmitter levels and its ability to increase quality of life in cancer patients, as well as relieve other cancer-related symptoms such as pain, has been documented. Methods: A systematic literature search was completed to identify all studies that assessed changes in depression symptom severity in patients receiving intravenous vitamin C treatment. The databases utilized include PubMed, Medline Complete, CINAHL Plus, Web of Science, Cochrane, and PMC. The inclusion criteria were: human participants with confirmed cancer of any type and stage, intravenous vitamin C treatment, with or without conventional treatment and with or without additional oral vitamin C dosing, and assessment of depression. Results: Out of 152 unique articles analyzed, four observational studies evaluate depression symptoms as part of an assessment of quality of life in cancer patients undergoing intravenous vitamin C treatment. All four studies reported improvement in mood. Discussion: The four included studies assessed the role of intravenous vitamin C in the treatment of depression in cancer patients. These studies confirmed previous research reporting improved quality of life and other cancer-related benefits (i.e. decreasing fatigue and pain). All four studies noted a decrease of depression in cancer patients which are summarized in Table 1. The included studies all evaluated safety and reported no significant adverse effects associated with the treatment. Conclusion: The current literature suggests that intravenous vitamin C could potentially have a beneficial effect on levels of depression in patients with cancer; however, more research is needed. Prospective clinical trials using validated assessment tools to capture changes in depression and control groups are needed to further study the potential role of this therapy in the treatment of depression in cancer patients.

Cost of Mental Illness and Depression in Developing Countries: A Case Study of Pakistan

Depression causes a substantial burden to persons, their beloved ones, and the nations as a whole. Major depression results in disability, high morbidity, high mortality, suicides, physical and mental impairment, and deteriorates the quality of life in a society. Depression is common in developing countries like Pakistan. This study analyzes the economic burden of depression and depressive disorders in Pakistan. The study was conducted in Pakistan’s third largest city, Faisalabad. Respondents were selected using a multistage sampling technique. As a first step, hospitals were selected from both the public and private sectors. In step two, respondents were selected and interviewed using a well-structured and pre-tested questionnaire. Review of literature reveals that the largest share of the burden of depression and depressive disorders is in the form of indirect cost. Direct healthcare cost is mostly in the form of outpatient care, doctor fee, and medicine bills, etc. This study, therefore, estimated both types of costs using cost of illness (COI) analysis. In order to find out the level of depression in patients, the center of epidemiologic studies depression (CES-D) scale was used. Then the direct and indirect cost of depression was estimated. Additionally, multiple regression analysis was used to examine the determinants of health cost, including the level of depression. The direct and indirect costs of depression were 11,108 Pakistani Rupees (PKR) and 4,869 PKR per month, respectively. Results of regression analysis revealed that besides the level of depression, monthly income, age, education, and the number of visits to a doctor’s clinic determine health cost, positively and statistically significant. Additionally, the occurrence of depression and anxiety was evident in adults more than other age groups. Females were suffering from this disorder comparatively more than male respondents. The economic burden related to depression is considerable, especially for those who belong to low-income group. Government should provide facilities for treatment for depression in public hospitals by keeping a special focus on less privileged groups of the population.

Neuroprotective and metabotropic effect of aerobic exercise training in female patients with type 2 diabetes mellitus

Abstract Objectives We aimed to evaluate the effects of acute and chronic aerobic exercise on cognitive function and depression levels in patients with Type 2 Diabetes Mellitus (T2DM) and the changes in related neurotrophic and metabotropic factors. Methods Sixteen female patients (age=57.5 ± 7.3) diagnosed with T2DM were included. A and B sections of the Trail Making Test (TMT) and Beck Depression Inventory (BDI) were used to assess executive function and depression states. Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), irisin, total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), fasting plasma glucose, hemoglobin A1c, and high-density lipoprotein (HDL) cholesterol were analyzed in blood. Aerobic exercise intensity was applied at 50–70% of the maximal heart rate for 40 min/day, three days weekly on the treadmill. All evaluations were repeated after one exercise session, a 12-week exercise program, and after one year for follow-up. Results TMT-A (p=0.001) and TMT-B (p=0.002) values were increased following both acute and chronic exercise. BDI scores were decreased after long-term exercise (p=0.031). Measurement of metabolic parameters revealed positive changes in HDL cholesterol (p=0.044), TAS (p=0.005), and OSI (p=0.009) values ​​after chronic period exercise. No significant difference was found in BDNF (p=0.271), NGF (p=0.230), and irisin (p=0.101) values ​​after acute or chronic exercise, on the other hand. Conclusions Although aerobic exercise training had a positive effect on metabolic and cognitive outcomes, this effect was independent of neurotrophic and metabotropic factors. Regular and long-term aerobic exercise training has protective and regulatory functions in T2DM.

Higher Depression Scores in Patients with Drug-Resistant Schizophrenia.

Schizophrenia is a mental illness with diverse clinical presentation, in which a significant proportion of patients show resistance to treatment. In patients with schizophrenia, symptoms from all psychotic and affective spectra are observed. On the one hand, affective symptoms determine the clinical course of schizophrenia and on the other hand, depressive symptoms are some of the most common ones in psychiatry in general. These data give us reason to explore the impact of depressive symptoms on the course of schizophrenia and its relationship with resistance to treatment. A study of 105 patients with schizophrenia was performed. Of these, 39 were male and 66 were female. The evaluation of the effectiveness of the treatment carried out at 12 weeks of therapy showed that 45 were resistant to schizophrenia and the remaining 60 were in clinical remission. The clinical evaluation of the patients was performed with the PANSS (Positive and Negative Syndrome Scale) and BPRS (Brief Psychiatric Rating Scale) scales. The assessment of depressive complaints was conducted with the Hamilton Depression Scale. Our study showed that in the analysis of depressive complaints with the Hamilton scale females got 12.55 points, and males got 11.44 points. We found a correlation of depressive complaints with the evaluation on the PANSS and BPRS scales, and in the analysis on the individual subscales we found a correlation on the subscale for positive and disorganized symptoms and no correlation on the scale for negative symptoms. We established a difference in the level of depression in patients with resistance in whom the level of depressive complaints was 13.82, while in those in clinical remission it was 10.87 points. The level of depressive symptoms in patients with resistant schizophrenia is higher than in clinical remission. Depressive symptoms correlate with positive and disorganized symptoms on the PANSS scale, but not with negative symptoms. Gender is not a determining factor in depressive complaints.

The relationship between stress, anxiety, and depression levels and pseudobulbar affect in patients with multiple sclerosis

Background Pseudobulbar affect (PBA) has recently been added to the list of mental disorders commonly observed in patients with Multiple Sclerosis (MS). The emotional changes experienced by MS patients may be associated with other mental problems and adversely affect disease prognosis. However, there are limited studies in the international and national literature on this subject. Aim This study aimed to evaluate the relationship between PBA and stress, anxiety, and depression levels in patients with MS. Design This is a descriptive, relational, and cross-sectional study. Methods A total of 442 MS patients followed in the neurology outpatient clinic of a hospital and registered with the MS Society in Turkey participated in this study. Data were collected using a personal information form, the Turkish version of the Center for Neurologic Study–Lability Scale (CNS-LS), and the Depression Anxiety Stress Scale (DASS). Results In this study, 63.3% of the patients had PBA, 21% had extremely severe depression, 41.6% had extremely severe anxiety, and 24.9% had severe stress. Correlation analysis revealed weak positive correlations between CNS-LS total score and DASS subscale and total scores. Depression, anxiety, and stress levels accounted for 22.5% of the variation in CNS-LS total score. Conclusion The results of this study indicate that a majority of MS patients in Turkey experience PBA, depression, anxiety, and stress, and that PBA is positively associated with depression, anxiety, and stress. Impact statement This study, indicates that should be increased consultation-liaison psychiatry services in Turkey, and MS patients should benefit from comprehensive psychiatric services.

Frequency of Depression Among Chronic Hepatitis C Patients Visiting Haji Abdul Qayyum Hospital Sahiwal

Hepatitis C is prominently a hepatic disease whose infection ranges in severity from a mild illness to serious lifelong complications. Multiple organ systems in the body may get affected. Depression is an important complication in almost 70% of HCV patients. Objectives: To find out the frequency of depression in chronic hepatitis C infected population of District Sahiwal. Methods: Descriptive cross-sectional study was performed at Gastroenterology Clinic, Haji Abdul Qayyum Hospital, Sahiwal during nine months from September 2020 to June 2021.Total 350 patients were selected by non - probability purposive sampling on the basis of preset inclusion and exclusion criteria. Beck’s Depression Inventory Scale was utilized to assess the patients for depression and correlate it with level of education and occupation. Results: Out of 350 patients of CHC, 56.6% were male and 43.4% were female. 4.3% patients were suffering from borderline depression; 42.3% were suffering from moderate depression; 46.3% were suffering from severe depression and 2.3 % were suffering from extreme depression. Association of depression with household income (p = 0.044) and duration of disease (p = 0.00) were significant while association of depression with level of education (p = 0.655) and occupation (p = 0.219) were not significant. Conclusion: Level of depression in patients of CHC is dangerously high. Level of depression in patients of CHC is strongly dependent on household income and duration of disease and independent of level of education and occupation.

The Language of Compassion: Hospital Chaplains’ Compassion Capacity Reduces Patient Depression via Other-Oriented, Inclusive Language

ObjectivesAlthough hospital chaplains play a critical role in delivering emotional and spiritual care to a broad range of both religious and non-religious patients, there is remarkably little research on the best practices or “active ingredients” of chaplain spiritual consults. Here, we examined how chaplains’ compassion capacity was associated with their linguistic behavior with hospitalized inpatients, and how their language in turn related to patient outcomes.MethodsHospital chaplains (n = 16) completed self-report measures that together were operationalized as self-reported “compassion capacity.” Next, chaplains conducted consultations with inpatients (n = 101) in five hospitals. Consultations were audio-recorded, transcribed, and analyzed using Linguistic Inquiry Word Count (LIWC). We used exploratory structural equation modeling to identify associations between chaplain-reported compassion capacity, chaplain linguistic behavior, and patient depression after the consultation.ResultsWe found that compassion capacity was significantly associated with chaplains’ LIWC clout scores, a variable that reflects a confident leadership, inclusive, and other-oriented linguistic style. Clout scores, in turn, were negatively associated with patient depression levels controlling for pre-consult distress, indicating that patients seen by chaplains displaying high levels of clout had lower levels of depression after the consultation. Compassion capacity exerted a statistically significant indirect effect on patient depression via increased clout language.ConclusionsThese findings inform our understanding of the linguistic patterns underlying compassionate and effective chaplain-patient consultations and contribute to a deeper understanding of the skillful means by which compassion may be manifest to reduce suffering and enhance well-being in individuals at their most vulnerable.

Benson Relaxation Technique Combined With Music Therapy for Fatigue, Anxiety, and Depression in Hemodialysis Patients: A Randomized Controlled Trial.

This study aimed to investigate the effects of the Benson relaxation technique combined with music therapy on fatigue, anxiety, and depression levels of patients undergoing hemodialysis. This randomized controlled study was conducted with 61 patients (30 patients in the intervention group, 31 patients in the control group) in a province located in Turkey. This 8-week, randomized, clinical trial was carried out in 2 hemodialysis units. After the patients in both groups were informed about the study, the Piper Fatigue Scale and the Hospital Anxiety and Depression Scale were administered to the patients. All subdomain scores of the Piper Fatigue Scale in the intervention group were significantly lower at weeks 4, 8, and 10 than those of the control group (P < .05). The intervention group had significantly lower Anxiety subscale scores than those of the control group at week 10 (P < .05). Similarly, Depression subscale scores were significantly lower in the intervention group at weeks 8 and 10 than those in the control group (P < .05). The findings suggest that Benson relaxation technique combined with music therapy is an effective approach to manage fatigue, anxiety, and depression symptoms related to hemodialysis.

Time-Varying Risk Factors Associated With the Progress of Functional Recovery and Psychological Distress in First-Ever Stroke Patients.

BACKGROUND: Evaluation of stroke recovery outcome is crucial and a major goal of clinical practice. A recovery trajectory model serves as a prognostic tool that enables development of effective intervention and long-term management to improve poststroke recovery outcomes. This study explored time-varying risk factors associated with the progression of functional recovery and psychological distress poststroke. METHODS: Participants were patients with first-ever stroke who underwent assessment for activities of daily living, psychological distress, and social support at the onset (within 72 hours) and at 1, 3, and 6 months. A generalized estimation equation was used to account for the correlation between the repeated measurements. RESULTS: Of the 101 patients, 60.4% were men, and the mean (SD) age was 63.06 (13.12) years. Over time, the physical functions of patients after stroke significantly increased, and anxiety and depression significantly decreased. Approximately 50% of patients achieved full functional recovery after 6 months. The time-varying risk factors for National Institutes of Health Stroke Scale scores and depression levels affected the trajectory of functional recovery during follow-up. Factors associated with patient anxiety levels were National Institutes of Health Stroke Scale scores and depression levels. Factors associated with patient depression levels included education, anxiety, and social support levels. CONCLUSION: This study demonstrates the progression of time-varying risk factors for functional recovery and psychological distress in patients with first-ever stroke. We recommend that nurses work with patients and their families in the early poststroke stages to identify comprehensive goals based on individual needs and related factors at different stages and that they educate patients on what is required for them to regain independence.

Evaluation of the Effects of Noninvasive Ventilation on Blood Gas and Depression Levels of Patients with Obesity Hypoventilation Syndrome.

Obesity hypoventilation syndrome (OHS) is associated with increased mechanical load on respiratory system. Here, we aimed to investigate and evaluate the effects of noninvasive ventilation (NIV) on physical and mental status of patients with OHS. The current study is an observational study that was performed in 2020 on 50 patients with OHS in Isfahan, Iran. Beck's Depression Inventory (BDI-II) and Hospital Anxiety and Depression Scale (HADS) questionnaires were also filled for all patients assessing their depression levels that were confirmed by psychiatrists. PO2 and PCO2 of patients were evaluated using venous blood gas (VBG) before interventions. Patients with a definite diagnosis of OHS and depression entered the study and underwent treatments with NIV. One month after the interventions with NIV, the blood gases of patients were evaluated using VBG and BDI-II, and HADS questionnaires were also filled for all patients, evaluating their depression. The mean age of the subjects was 63.5 ± 13.5. The mean blood oxygen after the use of NIV in patients with OHS increased significantly (P = 0.001). The mean of carbon dioxide after using NIV in patients with OHS decreased significantly (P = 0.001). Based on the BDI-II and HADS scales, the mean score of depression after using NIV decreased significantly (P = 0.001 for both). NIV therapies are associated with improvements in blood oxygen and CO2 of patients with OHS. The levels of depression also decreased after treatments that were confirmed by psychiatrists.

Personality characteristics, anxiety sensitivity, anxiety and depression levels of patients with premenstrual dysphoric disorder

Amaç: Bu çalışmada Premenstrual disforik bozukluk (PMDB), tanılı hastaların kişilik özelliklerini, anksiyete duyarlılığını, anksiyete ve depresyon düzeylerini değerlendirmeyi amaçlanmıştır.&#x0D; Gereç ve Yöntem: Çalışmaya, PMDB tanısı olan ve psikiyatrik tedavi öyküsü olmayan 40 hasta ve yine hasta grubuyla benzer sosyodemografik özelliklere sahip sistemik ve psikiyatrik hastalık öyküsü olmayan 40 sağlıklı kadın dahil edildi. Tüm katılımcılara Anksiyete-Duyarlılık-İndeksi-3 (ADİ-3), Beck Anksiyete Ölçeği (BAÖ), Beck Depresyon Ölçeği (BDÖ) ve Gözden Geçirilmiş Eysenck Kişilik Anketi-Kısaltılmış Formu (EKA-GGK) uygulandı. &#x0D; Bulgular: Hasta grubunun EKA-GGK nörotisizm, psikotizm, yalan alt ölçekleri ve toplam puanı kontrol grubunun puanından yüksek saptandı. Hasta grubunun ADİ-3 fiziksel, bilişsel, sosyal alt boyutları ve toplam puanı kontrol grubunun puanından yüksek olarak saptandı. PMDB tanılı hastaların BDÖ ile BAÖ ölçek puanı kontrol grubunun puanından yüksek bulundu.&#x0D; Sonuç: Anksiyete duyarlılığı yüksek olan, psikotizm ve nevrotik kişilik özelliklerine sahip kadınlarda bu durum PMDB gelişimini ya da hastalığın seyrini etkileyebilir.

Mekanisme Koping Berhubungan dengan Tingkat Depresi pada Pasien Diabetes Mellitus

This study aims to identify the relationship between coping mechanisms and the level of depression in patients with diabetes mellitus. This research method uses a cross-sectional approach. The results showed a relationship between the testing mechanism and the level of depression in patients with diabetes mellitus with a p-value = 0.000. Multiple logistic regression analysis was also performed to determine the most influential variable on the level of depression. It was found that coping mechanisms were predictors of depression (B = (2,158). ), SE=0.587, Wald=13,500, p value= 0.000. In conclusion, coping mechanisms are related to the level of depression. People with diabetes who use good coping mechanisms are stabbed eight times experience mild depression. People with diabetes exercise when experiencing problems well, using good coping mechanisms good. Keywords: Diabetes Mellitus, Coping Mechanism, Depression Level

DEPRESSIVE DISORDERS: IN POPULATION, IN GASTROENTEROLOGICAL PATIENTS AND IN COVID-19 PERIOD

Introduction. There are some data that suggest that emotional stress and depression may affect the development of functional organic disorders of the gastrointestinal tract. However, the relationship between them is not fully understood. It is not unknown the relationship between stress / depression and chronic gastritis. Aim: to analyze the published articles and online sources on depressive disorders with an emphasis on the impact of the COVID-19 pandemic, and investigate the depression level in patients with chronic atrophic gastritis with intestinal metaplasia, with or without gastric dysplasia. Materials and methods. Literature data were studied for 2004-2021 using Internet resources in English, Ukrainian, and Russian language. Using the HADS scale («The hospital Anxiety and Depression Scale»), the level of depression was studied in 76 patients with chronic atrophic gastritis (with intestinal metaplasia, with or without gastric dysplasia). Statistical data analysis was performed with SPSS Version 13.0. Results. Having used Internet resources and scientific publications, depressive manifestations, according to the International Classification of Diseases (ICD-10), diagnostic methods, the prevalence of depressive disorders before and during the pandemic COVID-19, as well as the impact of COVID-19 on the severity of depressive manifestations were studied. Additionally, it was found in this study that 23.7 % of patients with chronic atrophic gastritis had depressive changes. 13.2 % of these changes were subclinically expressed, and 10.5 % of ones were clinically expressed and required psychocorrective therapy. Conclusions. The COVID-19 pandemic is a trigger in society that may exacerbate depression in patients with other comorbid diseases and in the general population. Depressive changes requiring psychocorrective therapy were revealed in 23.7 % of patients with chronic atrophic gastritis with intestinal metaplasia. Keywords: Depression, general population, COVID-19, chronic atrophic gastritis, intestine metaplasia, dysplasia.